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palavras-chave 
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resumo 
 
 
O presente trabalho teve por objectivos realizar os primeiros estudos 
estruturais da versão humana da proteína p22HBP por RMN e ainda 
estudar a interacção de várias porfirinas com esta proteína usando a 
extinção da fluorescência intrínseca dos resíduos de triptofano. A 
realização destes objectivos pressupõe a optimização das condiçoes de 
produção e purificação da p22HBP humana, tendo-se testado para isso 
parâmetros com influência no total de proteína produzida e purificada. 
Esses parâmetros são o momemto da indução, a concentração do agente 
indutor e o tempo de lise celular por sonicação. Após a optimização das 
condições referidas, a produção da p22HBP tem lugar num meio de 
cultura contendo isótopos como 
15
NH4Cl e 
13
C-glucose, de modo a 
incorporar nas proteínas esses núcleos activos em RMN. O passo 
seguinte consistiu na identificação das ressonâncias da cadeia principal 
da p22HBP humana, primeiro passo e determinante na elucidação da 
estrutura tridimensional de qualquer proteína, por RMN. Por fim, foram 
realizados estudos de interacção usando o mapeamento das diferenças de 
desvio químico devidas à interacção com as porfirinas e, ainda a 
fluorescência intrínseca dos resíduos de triptofano para determinar a 
afinidade da proteína em relação às porfirinas. Estes estudos indicaram 
que o sítio de interacção presente na proteína é composta pelos mesmos 
resíduos previamente identificados no estudo com a murine HBP; para 
além disso, a constante de dissociação para as porfirinas situa-se na 
gama dos nanomolares, havendo portanto uma elevada afinidade. 
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abstract 
 
The present work aimed to perform the first structural studies on human 
p22HBP protein by NMR and at same time to study the interaction of 
some tetrapyrrole with this protein by fluorescence quenching. To 
accomplish these objectives we had to start by optimizing the conditions 
for producing and purifying human p22HBP. Parameters such as the 
moment of induction, the inducer concentration and time for cell lysis 
were evaluated. After the optimization, cultures of p22HBP in M9 
minimal media enriched with 
15
NH4Cl and 
13
C-glucose were grown. The 
first spectra of human p22HBP and the backbone resonance assignment, 
first and most important step in any protein structural elucidation by 
NMR, were performed. Finally, interaction studies were performed using 
chemical shift mapping and fluorescence quenching methods, and they 
indicated that the tetrapyrrole binding site is formed by the same residues 
described in   previous studies; and the dissociation constant by which 
human  p22 HBP binds PPIX and hemin was determined as being in the 
nanomolar range, being this interaction of high affinity.   
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Chapter 1 – Literature Review 
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1.1. Heme 
 
Heme is a tetrapyrrole with important biological roles and serves as a prosthetic group 
when linked covalently or non-covalently to specific hemoproteins in which it is the 
biological active center. It is essential for the transport of oxygen, for the production of 
cellular energy, in steroid biosynthesis or in signal transduction. In mammals heme is 
mainly utilized for hemoglobin synthesis in erythrocytes, myoglobin in muscle cells and 
for CYP450 in the liver. Despite being ubiquitous heme can be toxic when found in a 
free form due to the generation of ROS, which produces DNA damage, lipid 
peroxidation and protein denaturation 1.  
 
Heme (iron protoporphyrin IX) is a tetrapyrrole with a central iron ion that is 
synthesized by enzymes localized in two cellular compartments. The first and the last 
three enzymes from this biosynthetic pathway are localized in the mitochondrion, 
whereas the others are localized in the cytosol (Figure 1). The rate limiting step of 
heme biosynthesis is the formation of 5-aminolevulinic acid from glycine and succinyl 
CoA by ALAS. The last step is catalyzed by ferrochelatase, where ferrous is inserted 
into protoporphyrin IX. The quantitative expression and regulation of heme synthesis is 
different in various tissues and is mainly regulated by ALAS activity. ALAS have two 
distinct isoforms, an erythroid specific isozyme (ALAS2), and a non-specific 
housekeeping isozyme, which is expressed in the liver and other non-erythroid tissues 
(ALAS1). 
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Figure 1: The heme biosynthetic pathway. The pathway uses eight enzymes, four 
localized in the cytoplasm and four in the mitochondria 2. 
 
 
Heme synthesis takes place mostly in developing red blood cells in the marrow but 
about 15% of the daily production occurs in the liver for the formation of heme-
containing enzymes. However the regulatory mechanisms by which these two organs 
control heme synthesis are different. In the liver heme biosynthetic enzymes are turned 
over rapidly, enabling the liver to respond to changing metabolic requirements, in 
erythroid progenitors the pathway is regulated in order to allow a high steady-state of 
heme synthesis with regulation tied to the availability of iron 3. Adequate levels of heme 
are maintained through a combination of synthetic (uptake of extracellular heme into 
hepatocytes), and degradative mechanisms (via HO). Cells must possess a sensing 
system that allows them to monitor changes in the size of the uncommitted heme pool. 
Such system has not been identified but it seems that it may be linked to cytosolic 
heme-binding proteins because heme is toxic when in a non-bound form, poorly soluble 
in aqueous solutions at body pH and tends to form large aggregates at concentrations as 
low as 10-7 M. Several possible heme-binding and heme-transport proteins from the 
cytosol (FABP, GSTs and HBP23) have been documented 4. 
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1.2. The SOUL/HBP family 
 
In 1998 Taketani et al. reported a new heme-binding protein, expressed in high levels in 
various tissues with the highest levels having been verified in the liver, spleen and 
kidney. In addition it possessed a molecular mass of 22 kDa, the reason why it was 
called p22HBP. Studies of this protein after over-expression by molecular biology 
techniques showed that it binds heme, protoporphyrin IX and coproporphyrin with 
relatively high affinities 4. Later, in an attempt to identify genes expressed in retina and 
pineal gland in domestic chicken (Gallus gallus), a ckSoul gene was found, highly 
expressed in these organs 5. The ckSOUL sequence was used to find homologs in 
mammals and this search returned HBP.  Sequence comparisons indicate a high (87%) 
homology between mouse and human HBP proteins and much lower (24-28%) 
homology between ckSoul and mHBP and mSOUL (Figure 2). This indicates that 
mHBP, mSOUL and ckSOUL represent members of a new protein family (the 
SOUL/HBP family).  
 
 
 
 
Figure 2: Protein sequence alignment between p22 HBP, ckSOUL and mammalian 
SOUL using CLUSTALW. Identical amino acids are shaded in dark blue and similar 
residues are shaded in bright blue. The p22 HBP putative heme binding hydrophobic 
region (common to ckSOUL but not for mammalian SOUL) is delimited in red 4-5. 
Proposed His residue that axially binds the heme iron in mammalian SOUL is 
highlighted in red 6. 
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In 2002 Blackmon et al. reported Kd values ranging the µM,  for p22HBP upon binding 
heme and other tetrapyrroles (hemin and protoporphyrins), but it´s role in the cell have 
remained unknown until 2005 7. Babusiak et al. carried out a study in which isotopically 
labeled [59Fe]hemin was introduced into murine erythroleukemia cells and then the 
cellular lysates were separated by ion-exchange chromatography and the fractions 
containing radioactivity were collected and separated by native electrophoresis. The 
composition of the labeled protein complexes was analyzed by LC-MS/MS and in this 
way p22HBP was identified as a component in one of four multi-proteic complex 
associated with hemoglobin biosynthesis. They suggested that this protein can act as 
heme transporter or chaperone in insertion of heme into hemoglobin 8.  
 
In 2006, the three-dimensional structure (Figure 3) of murine p22HB, the first for a 
protein from SOUL/HBP family was determined by NMR to consist of a 9-stranded 
distorted β-barrel flanked by two long α-helices 9. Furthermore, the tetrapyrrole binding 
site was also determined by chemical shift mapping to a hydrophobic cleft formed by 
residues from helix αA and an extended loop (Figure 4). 
 
 
 
 
Figure 3: Resolved structure by NMR of murine p22HBP. a: ensemble of 20 
conformers; b: global view of p22HBP structure 9. 
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Figure 4: Model of the p22HBP-hemin complex 9. 
 
 
Recently, a molecular modeling study has been carried out in order to characterize the 
molecular recognition process that takes place upon the binding of HBP with 
intermediates of heme synthesis (i.e. hemin, PPIX). This study concluded that hemin 
and PPIX have identical binding orientations, in which the stabilization of the 
propionate side chains is mainly achieved by electrostatic interactions with lysine 177 
(position 176 in human) and arginine 56 located at the edges of the protein-binding 
pocket (Figure 5). Furthermore, the binding pocket of the human homologue is almost 
identical to the murine protein. The sequentially (and structurally) conserved lysine and 
arginine residues seem to play an identical role in stabilizing the tetrapyrrole propionate 
side chains in both proteins10. 
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Figure 5: Cross-eye stereo view of the apo mHBP protein-binding site with selected 
side chain residues of the binding pocket rendered in sticks10. 
 
 
1.3. Aims 
 
Everyday new proteins are found and the necessity for understanding their function 
grows. Human proteins have a special interest because knowledge of their roles in the 
cell may lead to the comprehension of metabolic processes and diseases. To obtain 
sufficient quantities of these proteins molecular biology techniques are required which 
results not only in sufficient amount but also adequate levels of purity for subsequent 
studies of structure and function. 
 
The comprehension of the structure and function of the proteins that interact with heme 
is essential to fully understand the transport and regulation of heme in biological 
systems. So far, the proteins of the HBP/SOUL family studied have been from a murine 
source (mHBP), so now, as a more relevant model for future mutagenesis studies, the 
first structural and interaction studies in the human version of the HBP is being 
attempted and the comparation with murine as well. As specific ally we want to: 
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1. Optimize the conditions for over-expression and purification of human version 
of p22HBP protein. 
 
2. Assign the backbone resonances of human p22HBP. 
 
3. Study the interaction of some porphyrins with this protein by chemical shift 
mapping and fluorescence quenching. 
9 
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2.1. Recombinant protein production 
 
One of the major challenges in large protein structural studies is the production of 
correctly folded protein and in enough quantities. Protein over-expression refers to the 
directed synthesis of large amounts of a desired protein and production of heterologous 
proteins involving the introduction of foreign DNA into the host cells 11. In the 1970´s 
new molecular biology techniques were developed allowing isolation and purification 
of target genes in a process called genetic cloning. Recombinant DNA technology, as 
these techniques are called, can be used to study mechanisms of replication and genetic 
expression, to determine gene sequences and ultimately the sequence of protein it 
encodes, and for development of cultures capable of producing pharmacologically 
active products 12. The first reported production of human recombinant protein took 
place during the 70’s by the biotech company Genentech that expressed the gene 
encoding somatostatin in E. coli. Later, in 1982, this company followed this success by 
producing humulin, recombinant insulin produced in E. coli and the first biotech drug to 
be accepted for market by the Food and Drug Administration 13-14. For production of 
any heterologous proteins one must be aware of some considerations: identification and 
isolation of the DNA to be introduced; identification of the vector and construction of 
recombinant vector; and identification of the suitable expression system to receive 
rDNA 15. 
 
In the beginning of the recombinant protein expression era the bacteria E. coli and 
Bacillus spp. were almost the only hosts that were used for recombinant expression. But 
the knowledge that a protein may require a specific host physiology and biochemistry to 
achieve optimal production has fired up the search for new hosts. There are two major 
categories of expression systems available, prokaryotic and eukaryotic. Prokaryotic 
systems are generally the most used but they have many limitations when using the cells 
for the production of eukaryotic proteins, e.g. many eukaryotic proteins undergo post-
translational modifications. However there is no universal expression system for 
heterologous proteins. All possess some advantages and also disadvantages that should 
be considered. Choosing the best expression system requires evaluating the options – 
from yield to glycosilation, to correct folding, to economics of scale-up 16. 
11 
 
2.2. Choosing an host system 
 
Bacterial expression systems are usually the primary choice for initial screening of 
recombinant expression and the reason lies in the cost-effectiveness of bacteria, its well-
characterized genetics, and the availability of many different bacterial expression 
strains.  E. coli is used extensively as it has a fast generation time (20-60 min depending 
on the growth media) and there are many tools available for gene cloning and 
expression. Starting in chemically defined media for growing, these cells can: be grown 
to very high densities; accept a wide variety of plasmids with a diversity of copy 
number; be used with inducible promoters with various strengths; be obtained with a 
wide range of plasmid systems that facilitate high-throughput cloning and expression. 
Several specialized strains have also been developed to overcome problems observed 
when over expressing proteins, e.g. strains with enhanced levels of tRNAs for rare 
codons, strains lacking specific proteases, strains with enhanced disulfide bond 
formation, etc 17. The major drawbacks of using E. coli for recombinant protein 
production are its lack of secretion systems for efficient release of proteins to the growth 
medium; inability to perform extensive disulfide-bond formation and other 
posttranslational modifications 18; beyond this, protein expressed  in large amounts 
often precipitate into insoluble aggregates called inclusion bodies; and initial lysis steps 
to recover cytoplasmatic proteins often results in the release of endotoxins, which must 
be removed from the final product 15.  
 
Of all eukaryotic hosts yeast is the most used alternative system for expression of 
foreign proteins because it can be grown relatively rapidly (doubling time 90 min) on 
simple media and to high cell densities. Its genetics is better known than any other 
eukaryote, so it can be manipulated readily and its complete genomic sequence is 
available. Finally it possesses stable high copy nuclear plasmids and finally has the 
ability to secrete the target protein. The major disadvantage of yeast as expression 
systems lies in the fact that it performs glycosilation in target proteins; however both N- 
and O-linked oligosaccharide structures are significantly different from their 
mammalian counterparts 15. 
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Baculoviruses have also emerged as a popular system for overproducing recombinant 
proteins in eukaryotic cells. Several factors have contributed to their popularity: they 
use many of the protein modification, processing, and transport systems present in 
higher eukaryotic cells; they use a helper-independent virus that can be propagated to 
high titers in insect cells adapted for growth in suspension cultures, making it possible 
to obtain large amounts of recombinant proteins with relative ease; and expressed 
proteins are usually expressed in the proper cellular compartment, i.e membrane 
proteins are usually localized to the membrane, nuclear proteins to the nucleus and 
secreted proteins secreted into the medium. The major drawbacks in expression using 
baculovirus are: since baculoviruses only infect invertebrates, it is possible that the 
processing of proteins produced by vertebrates is different and this seems to be the case 
for some post-translational modifications, e.g. internal proteolytic cleavages at arginine- 
or lysine-rich sequences are highly inefficient; the glycosylation capability is generally 
limited to producing only high mannose type and not processed to complex type 
oligosaccharides containing fucose, galactose and sialic acid 15.   
 
Ideally, proteins requiring mammalian post-translational modifications should be 
expressed in mammalian cells. If product authenticity is absolutely essential for clinical 
efficacy, then despite the many shortcomings, a mammalian host is the only choice, as it 
offers the greatest degree of product fidelity. It should, however, be noted that 
oligosaccharide processing is species- and cell type-dependent among mammalian cells. 
Differences in glycosilation pattern are reported in rodent cell lines and human tissues. 
Even the use of human cell line is not perfect, since the transformation event required in 
most cases to produce a stable cell line may itself result in altered glycosilation profiles. 
Also mammalian expression techniques are time consuming and much more difficult to 
perform on a large scale. Complex nutrient requirement and low product concentration 
have meant that the end product must be highly value-added for this approach to be 
commercially viable 15. 
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2.3. Choosing an expression vector 
 
At present there are a wide range of vectors available to introduce DNA into cells: 
plasmids, lambda phages, cosmids, phagmids, and artificial chromosomes from 
bacteria, yeast or human origin (BAC, YAC and HAC, respectively) 15. Most expression 
systems for E. coli make use of a plasmid, because it ensures easy cloning of the 
recombinant gene into the host cell, without need for chromosomal integration of the 
recombinant gene; furthermore plasmid-based systems allow many copies of the gene in 
a single cell. In general, expression vectors have the following attributes (Figure 6): 
 
·  Ori: Sequences that allow their autonomous replication within the cell. 
·  Promoter: A tightly regulated promoter, i.e. one which can be switched on and off 
easily.  
·  Selection marker(s): Sequences encoding a selectable marker that assures 
maintenance of the vector in the host. 
·  Terminator: A strong transcriptional terminator should be used with a strong 
promoter to ensure that the RNA polymerase disengages and does not continue to 
transcribe downstream genes. 
·  Polylinker: To simplify the insertion of the heterologous gene in the correct 
orientation within the vector 15. 
 
 
 
 
Figure 6: Design of a typical vector for heterologous gene expression MCS: multiple 
cloning sequence; Op: bacterial origin of replication; Mp: marker gene for selection in 
14 
 
eukaryotes; OE: eukaryotic origin of replication; PE: eukaryotic promoter sequence; TE: 
eukaryotic terminator sequence; hG: heterologous gene for expression 15. 
 
 
The most popular commercial vector system for E. coli is the Novagen pET system 
based on the T7 promoter. In this system the plasmid containing the target gene is 
transferred to an E. coli strain containing a chromosomal copy of the gene for T7 RNA 
polymerase. There are a great variety of cell strains that can be used in order to express 
proteins in E. coli. The most widely used cell strain is BL21 which does not encode Ion, 
ompT, and ompP proteases minimizing protein degradation during purification. There 
are different strains within BL21. For example, BL21(DE3) contains a T7 RNA 
polymerase gene that is integrated into the genome and that is under control of the 
lacUV5 promoter, which is a lactose analog IPTG inducible system. This means that the 
addiction of IPTG to a medium containing these cells will induce T7 RNA polymerase 
production which will ultimately transcribe the target gene in the plasmid (Figure 7) 19. 
 
 
 
 
Figure 7: Induction of the lac gene by IPTG, in the pET system 19. 
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The difference between BL21(DE3) and BL21(DE3)pLysS is that the pLysS strain has 
a plasmid encoding a T7 lysozyme gene that allows the expression of more toxic 
proteins in greater amounts since that gene is a natural inhibitor of T7 RNA polymerase 
and therefore, protein expression is tightly regulated. Moreover, the cell wall lysis in the 
purification step is greatly enhanced in pLysS strain compared to DE3 because the 
lysozyme induces the cell lysis in addition to the chosen method of cell disruption. 
Other strains (Table 1) that can be used for protein expression are the Tuner and 
derivatives (Rosetta and Origami B) which are lacY1 deletion mutants of BL21 and 
enable adjustable levels of protein expression throughout all cells in a culture. The 
lacY1 mutation allows uniform entry of IPTG into all cells in the population, which 
produces a concentration-dependant, homogenous level of induction. By adjusting the 
concentration of IPTG, expression can be regulated from very low level expression up 
to the robust, fully induced expression levels commonly associated with pET vectors. 
Lower level expression may enhance the solubility and activity of difficult target 
proteins 19. Rosetta strains are derived from BL21 lacZY and Tuner strains but they 
carry a pRARE derived plasmid that encodes several rare E. coli tRNA genes that can 
be encoded by a chloramphenicol resistant plasmid. Some of the rare codon genes are 
AGG/AGA (arginine), AUA (isoleucine), and CCC (proline). Therefore, these strains 
are designed to increase the expression of heterologous proteins whose genes encode 
numerous rare E. coli codons. Expression of these proteins can be dramatically 
increased when the level of rare tRNA is increased within the host. Origami strains have 
mutations in both the trxB and gor genes, which enhance disulfide bond formation in 
the cytoplasm. These strains are selectable on kanamycin, tetracycline, ampicillin, and 
chloramphenicol. OrigamiB is a derivative of origami and Tuner strains and it also 
contains trxB and gor mutations 19. 
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Table 1: Common applications of 5 E. coli strains. 
                                   Cell strain Comments 
General 
expression 
BL21 
T7-based expression upon IPTG 
induction. 
Toxic 
Protein 
BL21(DE3) 
The pLysS plasmid produces T7 lysozyme 
to reduce basal level expression of the 
gene of interest. 
Insoluble 
Protein 
Tuner (DE3) pLacI 
Contains a mutation in lacZY gene. This 
enables adjustment of protein expression 
by using different IPTG concentrations. 
   
Low 
Expression 
Rosetta (DE3) pLysS 
They supply tRNAs rarely used in E. coli 
providing a “universal” translation. 
OrigamiB (DE3) 
pLysS 
Contains mutations in thioredoxin 
reductase and glutathione reductase genes, 
which enhances disulfide bond formation 
in the cytoplasm. 
 
 
2.4. Purifying an recombinant protein 
2.4.1. Cell lyses – Sonication 
 
In some biotechnological applications the biological materials (i.e. proteins, enzymes, 
etc) to be purified and analyzed are found inside cells and must be released by means of 
a process called cellular lyses. Goals of cellular lyses are: to solubilize the maximum 
quantity of product inside cell without promoting loss of activity and unwanted 
secondary modifications of the product (i.e. denaturation, proteolysis and oxidation). 
Lysis must be fast and effective to get as much as possible of the material from inside 
cell, for subsequent purification. The techniques employed in lyses must be powerful 
enough to destroy membrane and cell wall but at same time they must be soft to avoid 
changing chemically and physically the materials that are found inside cell. The 
technologies used can be divided in two major groups: mechanical and non-mechanical. 
Mechanical methods break the cell totally by application of: pressure (i.e. French Press 
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and High Pressure Homogenizers); mechanical agitation (i.e. Bead Mills); and 
ultrasound (i.e. Sonication). The non-mechanical methods induce lysis by a physical 
process (i.e. osmotic shock, freezing/thawing), chemical degradation (i.e. detergents, 
organic solvents) or by a biological process (i.e. enzymes).  
 
 
2.4.2. Purification – IMAC (Immobilized Metal Affinity 
Chromatography)  
 
The purification of proteins from native or recombinant sources, in their biologically 
active form constitutes a step of major importance in molecular biology which aims to 
produce a relatively large quantity of purified proteins for subsequent use. Generally, 
before starting a purification procedure we must be aware of some considerations about 
proteins. They are easily degraded and modified by microorganisms, very sensitive to 
temperature, pH, salts, metals, etc. Knowing all this it is of extreme importance to plan 
precisely the purification procedure in terms of buffer composition, temperature, 
sequence and duration of the steps.  
 
Chromatographic methods are very powerful and extensively used for the purification 
or separation of mixtures. The reasons for this choice are the fact that they are 
economical and can give quantitative and qualitative information.  The general 
configuration is of a stationary phase (matrix) packaged in a column through which the 
mobile phase is eluted. The solutes in mobile phase (proteins, antibodies, peptides) are 
adsorbed in porous medium to be later removed by means of an eluent  resulting in 
separation of the different molecules 20. Depending on the column proteins can be 
separated by means of charge (ionic change chromatography), hydrophobicity (HIC – 
chromatography of hydrophobic interaction), size (GF – gel filtration) or capacity to 
link specific chemical groups (affinity chromatography – Ni-Sepharose). 
 
IMAC is a technique that was introduced in 1975. Is one of the most used methods for 
purifying polyhistidine-tagged recombinant proteins because it makes use of the natural 
tendency of histidine to form a complex with divalent metals around neutral pH (Figure 
8). Basically it explores the immobilization of the metal ion on a chromatographic resin 
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by chelation and so this allows the separation of the histidine-tagged proteins from most 
untagged proteins even under denaturing conditions. The binding interaction with the 
tagged protein is pH dependent. However the binding can be disrupted by eluting the 
sample from the resin by reducing the pH and increasing the ionic strength of the buffer 
or by including EDTA or imidazole in the buffer (Figure 9) 21.  
 
 
  
 
Figure 8: Interaction of histidine residues with Ni-NTA resin 22. 
 
 
 
 
 
Figure 9: Imidazole molecule simple and as part of histidine residue.  
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2.4.3. Evaluating protein expression level: SDS-PAGE 
(Sodium Dodecyl Sulphate Polyacrylamide Gel 
Electrophoresis) 
 
Electrophoresis is a technique for separation of molecules that uses the migration of 
molecules with charges in solution by means of the application of electric field. The rate 
of migration depends on the strength of the applied field, charge, size, shape, ionic 
strength, viscosity and temperature of the medium in which the molecules move. In 
non-native conditions detergents are used that will denaturate the proteins. This kind of 
electrophoresis is used to avoid interferences in the way that proteins are associated or 
folded. So denaturing and reducing agents are used to remove all levels of 
conformation. This method allows separation of proteins by molecular weight. It makes 
use of an anionic detergent, SDS (Sodium Dodecyl Sulphate) which links to proteins in 
an approximately 1 molecule of SDS to 3 amino acids giving them a negative charge 
that is proportional to their size. When denaturated proteins are introduced in an 
electrical field, they will move toward the positive pole (Figure 10). If a medium that 
allows proteins of different sizes move in different rates, the most used medium being 
polyacrilamide gel in which lower molecular weight proteins migrate at lower rates than 
higher ones. 
 
  
 
Figure 10: Electrophoresis system 23. 
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2.5. Structural studies 
2.5.1. Protein Structure Determination 
 
During the last decades there has been a huge growth in attempts to understand 
physiological processes at a molecular level. The secret of the genetic code has been 
discovered and we understand how this information is translated into proteins. The 
sequencing of whole genomes of several organisms including the human genome has 
also been carried out. Structural biology as a discipline started and includes the 
elucidation of the three dimensional structures of biological macromolecules and their 
interactions with other molecules in order to understand their biological function.  
 
For understanding the functions of complex biological processes, information regarding 
the structure and dynamics of macromolecules is of great importance. NMR 
spectroscopy and X-ray crystallography are the only biophysical methods which can 
provide high-resolution structures of biological molecules such as proteins and nucleic 
acids and their complexes at atomic resolution 24. The first protein structure 
determination was performed in 1959 by X-ray crystallography 25. Since then X-ray 
crystallography has dominated protein structure determination for decades although 
recently, NMR spectroscopy has evolved into a powerful technique that complements 
protein crystallography 26.  
 
When we take a look at Protein Data Bank we find that despite the growing number of 
proteins structures determined by NMR, X-ray crystallography is still the method that 
resolves most structures. X-ray crystallography is an older technique than NMR and a 
very robust method to obtain structural data of biomolecules but it has limitations: for 
crystallography we need crystals and not all proteins can be crystallized. On other hand 
the study of proteins by NMR is limited by the fact that not all the proteins can be 
solubilized in the concentrations required. Another drawback of x-ray crystallography is 
the fact that it determines a static molecule. The flexibility and dynamics of 
biomolecules are of great importance in the understanding of protein-protein and 
protein-ligand interactions and should be studied to obtain a complete picture. NMR is a 
powerful tool for structural studies because it allows us to study structural features in 
solution under a wide range of conditions such as temperature, pH and solvent. 
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Nowadays bimolecular NMR spectroscopy is a robust method used to get information 
about conformational dynamics and exchange processes of biomolecules at timescales 
ranging from picoseconds to seconds and is very efficient in determining ligand binding 
and mapping interaction surfaces of protein/ligand complexes 24. 
 
 
2.5.2. Protein sequence-specific assignment 
 
 
 
 
Figure 11: Flowchart of protein structure determination by NMR spectroscopy. The 
sequence-specific resonance assignment that is emphasized by bold plays a key role in 
protein structure determination 27. 
 
 
 
Sample preparation is a very important step in structure elucidation (Figure 11). After 
producing a recombinant protein using an adequate host and expression system the last 
step for NMR sample purification is to choose a good buffer in which the protein is 
concentrated to approximately 1 mM. Phosphate buffer at pH 5–7 (20–50 mM) with or 
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without salt (e.g., KCl, NaCl) is often used for many NMR samples. High quality NMR 
tubes should be used for protein samples, which are usually tubes 5 mm in diameter 
containing 0.5 ml 95% H2O?5% 2H2O for aqueous samples. If the volume of the sample 
is limited, microtubes for which the susceptibility matches that of 2H2O are chosen for a 
total sample volume of approximately 200 μl, such as Shigemi micro tubes (Shigemi 
Inc., Allison Park, PA). The buffer contains from 5-7% 2H2O used for 
2H lock. In 
addition, the samples are usually required to be degassed by blowing high purity argon 
or nitrogen gas into them to remove oxygen—the paramagnetic property of which will 
broaden the line shapes of protein resonances 28. 
 
 
2.5.2.1. Sequential resonance assignment in unlabeled and 
15
N 
labeled proteins 
 
The application of two-dimensional NMR methods to proteins was for the first time 
carried out in the early 1980s by Kurt Wuthrich and it revolutionized the application of 
NMR for structure determination of macromolecules 29. These methods were developed 
for unlabeled proteins and allowed small proteins (up to 10-12 kDa) to be assigned and 
distance restraints to be obtained. The first step in any structural studies of biomolecules 
by NMR is complete resonance assignment. For this step the methods developed by 
Wuthrich and co-workers are of great importance because they are based on the 
identification of spin systems within individual amino acids by through-bond 1H-1H 
connectivity measured using COSY and total TOCSY. Sequential conectivities between 
neighboring amino acids via NOESY are subsequently carried out. 2D NMR solved the 
problem of signal overlap. However the increasing number of signals made resolution to 
decrease and also the sensitivity due to intensity losses during the additional 
magnetization transfers. Therefore longer measurements times are needed. 
 
At the end of 1980’s developments in three-dimensional homonuclear experiments 
made it possible to overcome problems of linewidth and number of signals seen in 
bigger proteins. The elucidation of the structure of large biomolecules has evolved 
along with protein expression techniques that makes possible to obtain large amounts of 
23 
 
proteins and, if necessary labeled with NMR active nuclei such as 13C and 15N. These 
improvements have resulted in a substantial increase in assignment strategies because of 
developments in double and triple-resonance NMR experiments that makes use of 
uniformly 13C/15N-labeled proteins. Concluding, the advances in molecular biology 
techniques have extended the assignment to molecular masses up to 15-20 kDa. 
Recently, the introduction of 2H/13C/15N-labeling and the TROSY technique has 
extended even more the limits towards 100 kDa 30. The introduction of a third frequency 
dimension (13C) in protein NMR allowed the signals in 2D and 3D spectra to be spread 
further reducing overlap (Figure 12). The introduction of a third dimension 15N made 
the NMR spectra less complex than homonuclear 3D because it gave the opportunity to 
make assignment based on the 1H,15N correlation which is specific for every individual 
amino acid in the chain. 
 
 
 
 
 
 
Figure 12: Protein NMR 1D (left) and 2D (right) 31. 
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2.5.2.2. Assignment of uniformly 
13
C/
15
N-labeled proteins 
using triple resonance experiments 
 
Assignments based on triple-resonance experiments make use of efficient magnetization 
transfer through coupled heteronuclear spins (1H, 13C and 15N). Nowadays many three-
dimensional (3D) triple-resonance NMR experiments are available to allow the 
sequential backbone assignment for large proteins. The names of these experiments are 
related to the nuclei they correlate. For example, the experiment that transfers 
magnetization from the amide proton (HN) via the amide nitrogen (N) to the carbonyl 
C´(CO) of the previous residue is called HNCO. If we include another step of 
magnetization transfer to the Cα (CA) of the previous residue then the experiment is 
referred to as H(N)COCA, being that the parenthesis means that the magnetization is 
only transferred via the nitrogen spin, without chemical shift evolution (Figure 13). 
 
 
 
Figure 13: Spin system of the peptide backbone and size of the 1J and 2J coupling 
constants that are used for magnetization transfer in 13C and 15N-labelled proteins 32. 
 
 
In Figure 14, the triple resonance experiments used during backbone spins assignment 
are shown. The HNCA experiment correlates the 1H from the backbone amide group 
with the attached 15N and the 13Cα of the same amino acid. In addition, the 13Cα of the 
previous residue in the protein sequence can be also detected. The HN(CO)CA 
experiment correlates the 1H from the backbone amide group with the attached 15N and 
the 13Cα of the previous amino acid in the protein sequence. Both experiments, 
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HNCA/HN(CO)CA, have complementary information allowing the identification of 
1HN, 15N and 13C resonances and the attribution of sequential connectivities. The same 
goes for HNCO/HN(CA)CO and HN(CO)CACB/HNCACB experiments which allows 
the sequential assignment of the proteins under study. 
 
 
 
 
Figure 14: Heteronuclear 3D NMR experiments and correlations, respectively.  
 
 
In Table 2 we have the average chemical shifts of active nucleus (H, C and N) that are 
present in the 20 naturally amino acids present in proteins. This table can be really 
helpful upon the assignment of the resonances because some systems appear in a 
specific region of spectra, being directly just to look to the spectrum (i.e.13Cα for 
glycines). 
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Table 2: The statistics presented in this table were calculated from the full BMRB 
database.  This includes only the diamagnetic proteins. The calculated statistics are 
drived from a total of 4603403 chemical shifts in the 20 natural amino acids found in 
proteins (adapted from BIOLOGICAL MAGNETIC RESONANCE BANK – BMRB 
Database, 2011) 
Residue H
N
 H
α 13
CO 
13
Cα 
13
Cβ 
15
N 
ALA 8.19 4.26 177.73 53.15 19 123.22 
ARG 8.24 4.3 176.42 56.79 30.68 120.78 
ASP 8.31 4.59 176.40 54.69 40.88 120.65 
ASN 8.34 4.67 175.27 53.54 38.69 118.93 
CYS 8.39 4.66 174.87 58.24 32.66 120.13 
GLU 8.33 4.25 176.89 57.35 30 120.66 
GLN 8.22 4.27 176.32 56.59 29.18 119.88 
GLY 8.33 3.94 173.88 45.36 - 109.65 
HIS 8.25 4.61 175.25 56.49 30.24 119.66 
ILE 8.27 4.18 175.85 61.63 38.61 121.45 
LEU 8.22 4.32 176.99 55.64 42.30 121.83 
LYS 8.18 4.26 176.65 56.96 32.77 121.04 
MET 8.26 4.41 176.2 56.12 32.99 120.09 
PHE 8.36 4.63 175.43 58.11 39.95 120.47 
PRO - 4.4 176.73 63.34 31.85 133.96 
SER 8.28 4.48 174.64 58.74 63.79 116.26 
THR 8.24 4.46 174.57 62.23 69.72 115.41 
TRP 8.29 4.68 176.13 57.68 29.98 121.67 
TYR 8.32 4.63 175.4 58.13 39.32 120.52 
VAL 8.29 4.18 175.63 62.51 32.72 121.12 
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2.5.3. TROSY (Transverse Optimized Relaxation 
Spectroscopy) in the study of large proteins 
 
The foundations of NMR resonance assignment studies are high-quality NMR spectra 
recorded with good S/N ratio and spectral resolution. However, with increasing 
molecular weight these requirements become harder to achieve. The limiting factors are 
sensitivity and line broadening due to rapid transverse spin relaxation and extensive 
signal overlap due to the high complexity of the spectra. Recent advances have been 
achieved with both novel NMR techniques and new biochemical approaches. In 
particular, using the NMR technique Transverse Relaxation-Optimized Spectroscopy 
(TROSY) in combination with suitable isotope labeling schemes, the size limit for the 
observation of NMR signals in solution has been extended severalfold 33-34. 
 
The TROSY (transverse relaxation-optimized spectroscopy) technique has been 
developed to reduce relaxation losses during the chemical shift evolution of a 
heteronucleus X (e. g. 15N), the X→ 1H magnetization transfer and the acquisition time. 
The transverse relaxation rate is mainly caused by DD coupling and CSA. Considering 
the components of a doublet of I in a weakly coupled two spin system IS the transverse 
relaxation rates are different due to addition or subtraction of the influence of DD 
coupling and the CSA. A narrow and a broad component is the result. In a non-
decoupled two-dimensional 15N-HSQC spectrum only one component of the quartet has 
a narrow line width in both dimensions (the TROSY component) as shown in below. 
TROSY experiments select solely these narrow components and suppress the broad 
components of the quartets (Figure 15). Note that the signals in a TROSY experiment 
are shifted in both dimensions by ½JNH. To summarize, TROSY suppresses transverse 
relaxation, e. g. in 15N-1H moieties by constructive use of interference between DD 
coupling and CSA 31. 
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Figure 15: (a) conventional 15N-HSQC with decoupling in both dimensions, (b) 15N-
HSQC without decoupling in both dimensions and (c) 15N TROSY which selects only 
the narrow component 31. 
 
 
 
The TROSY technique can be implemented in every NH detected triple-resonance 
experiment and is widely used combined with triple resonance experiments. The 
advantages are higher resolution of the experiments and smaller half height line widths. 
Therefore the separation of signals in the 15N,1H plane is better 35.  
 
 
2.6. Interaction studies 
 
Generally, the biological function of a protein is intimately related to its interaction with 
ligands. Examples are the interaction of hormone receptors with hormones, that trigger 
complicated signal cascades, or the interaction of certain proteins with nucleic acid 
sequences to regulate gene replication, transcription, or translation, or the highly 
specific interaction of cell-surface antigens with receptors located on other cells 36. 
Protein-ligand interactions are an extremely important field of study. Information on 
protein-ligand interactions not only plays an integral role in the fundamental 
investigation of any enzyme, cellular receptor, or other large biomolecules and the study 
of its binding properties, but is also important because of its utility in the discovery and 
development of new drugs. Nowadays there is a large list of techniques used to access 
this kind of information, but in this thesis we will focus in two of them, fluorescence 
quenching and chemical shift mapping. 
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2.6.1. Chemical shift mapping 
 
NMR can be used to solve 3D structures in solution; however it is also a very powerful 
tool for accessing interactions between macromolecules and various ligands. This 
interactions can be assessed at a wide variety of levels, being the chemical shift 
mapping being one of the possible approaches 37. In theory, upon binding phenomenon 
of a ligand to a receptor protein, the chemical shifts of both ligand and protein proton 
resonance signals will be affected. For the protein, the most affected resonances are 
from the nuclei located in the binding pocket (Figure 16). The acquisition of 1H/15N 
HSQC spectra and assignment of the spin systems with and without ligand present is, 
generally one of the possible experimental setups to detect ligand binding and at same 
time identify the amino acids present in the binding pocket. The technique only requires 
that 15N-labeled protein is available 36. 
 
 
 
 
Figure 16: TROSY of chemical shift perturbation upon binding of murine p22HBP 
(black) to PPIX (blue) and hemin green) 9. 
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2.6.2. Fluorescence quenching 
 
The interactions of proteins with other molecules are of great importance because they 
are responsible for the majority of molecular complexes that makes life possible. So it is 
of great importance to quantify the number and binding strength of protein-ligand 
interactions.  Fluorescence techniques are largely used to study these kinds of 
interactions because of the sensitivity of the technique which allows it to be used in real 
equilibrium situations 38. Luminescence is the emission of light from any substance and 
it takes place from electronically excited states. Luminescence can be divided into 
fluorescence and phosphorescence depending on the nature of the excited state. In the 
singlet excited state, an electron in the excited orbital is paired (opposed spin) with an 
electron in the ground state. Here the return to the ground state of the excited electron is 
allowed and occurs rapidly (fluorescence). Phosphorescence is the emission of light 
from triplet excited states, in which the electron in the excited orbital has the same spin 
orientation as the electron in ground state. Here the transitions from excited to ground 
are not allowed the return to ground state is much slower than in fluorescence (Figure 
17) 39. 
 
 
 
Figure 17: Jablonsky diagram showing the light absorption and emission phenomenon 
39.   
 
Fluorescence quenching refers to any process that diminishes the sample fluorescence 
intensity. A large range of molecular interactions can result in quenching. These include 
excited state reactions, molecular rearrangements, energy transfer and collisional 
31
 
quenching. Fluorescence quenching has been largely studied both as fundamental 
phenomenon and as source of information for biochemical systems.  Biochemical 
applications are related to the role of intrinsic interactions in quenching. Both static and 
dynamic quenching requires molecular contact between fluorophore and quencher. In 
collisional quenching, the quencher has to collide with the fluorophore for the excited 
state lifetime. Due to this contact, the fluorophore returns to the fundamental state 
without photon emission. Generally quenching occurs without any definitive change in 
the molecules or without any photochemical reaction. In the static quenching situation a 
complex is formed between fluorophore and the quencher and this complex is not 
fluorescent. The discussion of biochemical fluorescence generally concentrates on 
proteins. This is due to the fact that only proteins possess a useful intrinsic fluorescence. 
Lipids, membranes and saccharides do not present fluorescence and the intrinsic DNA 
fluorescence is too weak to extract important information. In proteins, the aromatic 
amino acids phenylalanine, tyrosine and tryptophan present fluorescence. A great 
advantage of proteic structure is the fact that these three amino acids are relatively rare 
in proteins. Of the three, the most abundant is tryptophan but its only present in 1% 
(mol) in proteins. An important characteristic of protein intrinsic fluorescence is the 
high sensitivity of tryptophan to its local environment. We can watch changes in 
tryptophan emission spectra in response to protein conformational changes, subunit 
association, substrate binding or denaturation, as the local environment which surrounds 
indol ring is modified (Figure 18) 39. 
 
 
Figure 18: Tryptophan intrinsic fluorescence in murine p22HBP upon titration with 
PPIX and hemin 9. 
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Chapter 3 – Materials and Methods 
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3.1. Human p22HBP expression system construction  
 
The gene encoding N-terminal domain of Homo sapiens recombinant p22HBP 
(GenBank accession number NP_057071) (Figure 19), consisting of aminoacids 1 to 
189 (Figure 20), was subcloned in Nco l and Xho l sites into similarly restricted 
pET28a expression vector (Novagen), after the T7 promoter and the His-Tag (Figure 
21). This plasmid was used to transform E. coli strain BL21 (DE3), a step carried out by 
Nzytech (genes & enzymes, Ltd). Long-term storage of hosts is best carried out as 
glycerol stocks. For this purpose after growing a culture containing kanamycin until the 
OD600 reached 0.6-0.8 we removed 0.375 mL and transferred them to an autoclavated 
eppendorf tube and added 0.125 mL 80% glycerol. After mixing well the eppendorfs 
were stored at -70ºC. To inoculate a culture from the frozen stocks a few microliters at 
the thawed stock is pippeted to fresh medium. 
 
 
 
 
Figure 19: Optimized sequence of the gene encoding recombinant Homo sapiens 
p22HBP. Start and Stop codons underlined. 
 
 
 
 
Figure 20: Homo sapiens p22HBP protein sequence. RED: His-Tag. 
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Figure 21: pET-28a map.  
 
 
 
 
 
 
 
 
 
 
 
35 
 
3.2. Human p22HBP overexpression, lysis and purification 
3.2.1. Overexpression 
 
Luria Bertani medium was used for the growth of the BL21(DE3) strain and M9 
Medium was used for induction of recombinant protein expression. 
 
 
LB Medium 
 
Tryptone, yeast extract, NaCl; deionized water to 1 liter (pH 7.5). 
Sterilize by autoclaving. 
M9 Medium  
(Minimal) 
50 ml 10xM9 salts* plus 950 mL deionized H2O. Sterilize by 
autoclaving.  
*10xM9 salts 
128 g Na2HPO4.12 H2O; 30 g KH2PO4; 5 g NaCl; 10 g (NH4)Cl. 
For 15N labeled protein production, use 1 g 15(NH4)Cl 
(CORTECNET, France) moments before cell inoculation. 
 
 
The cells were grown using a standard procedure in which LB medium is used to 
achieve good cell density and a M9 minimum  medium is subsequently use for 
induction (Figure 22). For overexpression purposes,  starter cultures were prepared by 
inoculating 20 µL of cells taken from glycerol stocks in 20 mL of LB media previously 
autoclaved and supplemented with kanamycin, and incubated at 37ºC with shaking at 
180 rpm for 12 to 16 hours (overnight). The culture was then inoculated into LB 
medium, 3 mL of starter culture for 150 mL of LB, and incubated for 5 hours at 37 ºC 
and 180 rpm. The cells were then harvested by centrifugation at 8000 rpm for 10 min at 
4ºC and ressuspended into a freshly prepared M9 medium supplemented with 
kanamycin and nutrients. For testing the time of induction, 4 flasks were used. In one 
flask the cells were induced at the time of ressuspension in M9 medium; in the second 
the cells were induced after 1h in M9 medium at 30ºC and 180rpm; in third and fourth 
the induction was performed after 2 and 4h respectively. For testing inducer 
concentration, 4 flasks were used and to each was added a different stock concentration 
of 150 µL of IPTG (0, 0.1, 0.5 and 1M) after 2h in M9 medium at 30ºC and 180 rpm 
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(Table 3). After induction, all cells were incubated at 30ºC and 180rpm for 16h 
(overnight).  
 
 
Table 3: Parameters tested for the human p22HBP over-expression optimization. 
Time of induction (hours) IPTG concentration (mM) ± 0.040 
0 0 
1 0.1 
2 0.5 
4 1 
 
 
 
 
 
 
Figure 22: Sequential steps of overexpression of the human p22HBP.   
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3.2.2.  Purification 
 
After 16h of induction in M9 medium, the cells were recovered by centrifugation at 
8000 rpm for 10 min and resuspended in a 50 mM KH2PO4/300 mM NaCl buffer at pH 
8.0. For optimization purposes cells lysates were sonicated for 6, 12 and 20 minutes (59 
seconds with 59 second intervals) while the suspension was kept on ice to prevent 
heating. Centrifugation at 20000 rpm at 4ºC for 1h was applied to separate the 
homogenate components into cytoplasmatic fraction (supernatant) and cell pellet. The 
supernatant was then applied to a Ni-NTA column with Sepharose matrix functionalized 
with chelating groups charged with Ni
2+
 for purification. The system was equilibrated 
with 50 mM KH2PO4/300 mM NaCl buffer and the purification procedure was 
performed under native conditions. The hist-tagged protein was eluted using an 
imidazole gradient (10-500 mM) (Figure 23). The purest fractions containing human 
p22HBP were pooled together and concentrated using 10 kDa centricons (Millipore) to 
2.5 mL. This volume was applied to a PD-10 Desalting column (Amersham 
Biosciences), previously equilibrated with 20 mL of 50 mM phosphate buffer and eluted 
with this buffer to a final volume of 3.5 mL.  
 
 
 
Figure 23: Sequential steps of purification of the human p22HBP. 
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3.2.3. Denaturing gel electrophoresis 
 
SDS-PAGE was used to examine purity of the protein separation as well as to determine 
its molecular weight. A Vertical Mini-Protean 3 unit (BioRad) was assembled for SDS-
PAGE gel running with a 15% running gel and 4% stacking gel prepared prior to 
electrophoresis. The separating gel was prepared by adding 1.7 ml of H2O, 2.5 mL Tris-
HCl 1.5 M at pH8.8, 3.7 mL of 40% acrylamide, 2.01 mL of 2% Bis-acrylamide, 100 
uL of 10% SDS, 50 uL of 10% APS and 5 uL of 5μl of TEMED. A layer of water was 
gently loaded onto the top of the separating gel to flatten the gel surfaces and remove 
trapped bubbles. Subsequently, the water was removed from the gel cassette. The 
stacking gel, composed of 2.9 mL H2O, 1.25 mL Tris-HCl 1.5 M at pH6.8, 500 μL of 
40% acrylamide, 250 μL of 2% Bis-acrylamide, 50 μL of 10% SDS, 25 μL of 10% APS 
and 5 uL of 5μl of TEMED, was pipetted on the separating gel. A comb was inserted 
into the stacking gel before polymerization occurred. Each of the samples was mixed 
with 125 μl of Tris-HCl 1.5 M at pH 6.8, 75 μL glycerol, 200 μL of 2% SDS, 100 μL of 
2-mercaptoethanol and bromophenol blue, followed by subsequent denaturing step at 
heating at 95°C for 5 minutes. Next, the samples together with the SDS marker were 
loaded into the respective wells of the SDS-PAGE gel. The gel was covered then with 
water and left to boil in a microwave oven, followed by 5 min of cooling at room 
temperature with slow shaking. The water was then removed and fresh water added to 
the gel and the procedure repeated 2 times. For the last cycle, the gel was stained with 
Coomassie Blue before the microwave step (containing 70 mg of Coomassie Blue 
G250). After removing the Coomassie solution, water was added to the gel and shaking 
for 2 min. 
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3.2.4. UV-Visible Spectroscopy 
 
UV-Visible absorption measurements (at selected wavelengths or as 190-600 nm 
spectra) were recorded on a UV-visible spectrophotometer interfaced with a personal 
computer using the Chemstation Software for Windows. Optical measurement was 
performed at room temperature. Purified protein samples were quantified by UV-Vis 
spectrophotometric method, according to the Lambert-Beer law, by measuring the 
absorption at 280 nm (A280) (Equation 1).  
 
 
 
 
Equation 1: Equation used for the determination of the human p22HBP concentration. 
Where A(λ) and ε(λ) are the absorption and molar absortivity at 280 nm, c is the protein 
concentration in M and d is the thickness of the cell (1 cm).  
 
 
A theoretical value for molar absortivity of the human p22HBP was calculated by the 
Expasy protparameter tool and gave 35535 M-1cm-1. For calculation of the real 
(experimental) value to be use, a sample of 37 µM of the protein was diluted 1:2, 1:3, 
1:4, 1:5, 1:10 and 1:20 and a graph of absorbance as a function of the concentration was 
plotted (Figure 24). The experimental value for human p22HBP was found to be 35686 
M-1cm-1. 
 
 
 
Figure 24: Plot of Absorbance values at 280 nm as a function of protein concentration. 
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3.3. Mass Spectrometry 
 
A mass spectrum of 1.0 nM human p22HBP (prepared from dilution of a sample 
containing 20 µM of protein), was obtained on a matrix assisted laser 
desorption/ionization–time of flight MALDI TOF/TOF mass spectrometer (4800 
Proteomics Analyzer, Applied Biosystems, Foster City, CA, USA) in the linear mid 
mass positive ion mode and obtained in the mass range from 5000-80000 Da with 1650 
laser shots, using alpha-cyano-4-hydroxycinnamic acid as a matrix. 
 
 
3.4. Fluorescence Quenching  
 
The p22HBP samples used in the fluorescence quenching experiments were diluted 
from a 0.2 mM stock solution with 50 mM KH2PO4 at pH 8.0 and the protein 
concentration of the stock solution was estimated by UV spectroscopy using a molar 
extinction coefficient at 280 nm (ε280) of 35686 M
-1cm-1. Hemin and PPIX solutions 
were dissolved in ammonia followed by dilution in water. For the fluorescence 
quenching experiments 1 mg of hemin and PPIX were dissolved in ammonia followed 
by dilution in water. The surfactant Tween 80 was added to a final concentration of 
1.5% (v/v) and the pH was adjusted to 8.0 by adding 1M NaH2PO4. The final 
concentrations prepared for both tetrapyrrole were 5 and 10 μM. In the fluorescence 
quenching experiments increasing volumes of the porphyrins were added to 2 mL of 
protein at 100 nM and the fluorescence intensities were registered (Table A1 
(Appendix)). After each addition the reaction was gently homogenized and left to 
equilibrate for 1 minute. Each titration experiment was repeated two times and with 
different preparations of porphyrin dilutions. Determination of the KD values were 
performed by plotting the human p22 HBP emission maxima as a function of porphyrin 
concentration. In addition a fitting (OriginPro software) was made with the data 
obtainted by using Equation 1 9.  
 
 
Equation 2: p22 HBP emission maxima (y) as a function of porphyrin concentration (x). 
Where I0 and Iint are emission intensities at zero and saturating porphyrin concentrations, 
respectively and [HBP] is the protein concentration. 
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3.5. Nuclear Magnetic Resonance Spectroscopy 
3.5.1. Protein overexpression and purification  
 
The bacterial growth was performed in 2 L LB medium, at 37ºC and 180 rpm, until an 
OD600 of about 0.6-0.8 was obtained. The cells were harvested by centrifugation at 
8000 rpm for 10 min and resuspended in M9 medium (minimal growth medium) where 
15N-labeled NH4Cl and/or 
13C-glucose  was used as sole carbon source. The cells were 
let to grow for 2 h at 30ºC and 180 rpm. After then the protein induction was then 
started with the addition of isopropyl-β-D-thiogalactopyranoside (IPTG) 0.5 mM and 
continued overnight at 30ºC. Protein purification was achieved as described in section 
4.2.2.  
 
 
3.5.2. Nuclear Magnetic Resonance spectroscopy 
experiments 
 
For the sequential assignment of the human p22HBP, a uniformly 15N/13C-labeled 
sample (50 mM phosphate buffer, pH 8.0) in H2O/D2O (7%) at a concentration of 1 mM 
was used. All NMR spectra (Table 4) were acquired at 293 K on a Bruker DRX600 
spectrometer equipped with a four-channel probe and triple axis gradients. The 
assignments of 1H, 15N, 13CO and 13Cα chemical shifts were determined by a series of 
TROSY-type triple resonance experiments: HNCO, HNCA and HN(CO)CA. All the 
experiments were processed and analyzed by NMRPipe/NMRDraw (DELAGLIO et al.) 
and CARA (DAMBERGER et al.).  
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Table 4: Table listing the NMR experiments performed or structural studies. 
Experiment 
Base 
frequency 
1
H (MHz) 
1
H sweep 
width (Hz) 
13
C sweep 
width (Hz) 
15
N sweep 
width 
(Hz) 
Acquisition 
time 
TROSY 
600 
8417.509  2432.713 2h 47min 
tr-HNCA 10775.863 4829.15 2189.445 1day1 4h 40min 
trHN(CO)CA 10775.863 4829.15 2189.445 2days 2h 27min 
trHNCO 10775.862 3320.46 2189.445 1day 3h 21min 
 
 
 
3.5.3. Chemical shit perturbation mapping 
 
The porphyrins stock solutions were prepared as previously described for the 
fluorescence quenching experiments. Titration experiments were performed with 
uniformly 15N-labeled human p22HBP using three samples: human p22HBP:hemin and 
human p22HBP:PPIX (0.5 mM protein, 50 mM KH2PO4 buffer, pH 8.0, 7% 
2H2O). A 
blank solution (where no porphyrin was added) was also prepared to match the 
porphyrins solution conditions (50 mM KH2PO4 at pH 8.0 with Tween 80 at 1.5% 
(v/v)).  The p22 HBP NMR samples were prepared by dilution of a 0.2 mM 15N p22 
HBP stock solution to 1 mM in 50 mM KH2PO4 pH 8.0 by adding 1.1 moles of 
porphyrin solution. The final volume was completed with the blank solution so that all 
the samples were under the same buffer conditions. 
 
The spectra were acquired at 293 K, on Bruker spectrometer (500 MHz 1H frequency) 
triple axis gradients. 1H, 15N TROSY spectra were acquired using a spectral width of 
8012.82 Hz for 1H and 2027.351 Hz for 15N. The NMR data were processed as referred 
in section 4.5.2.   
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Chapter 4 – Results and Discussion 
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4.1. Optimizing human p22HBP overexpression, lyses and 
purification  
 
In order to determine the optimum starting time for induction, four shake-flask 
fermentations were performed in parallel, and each culture was induced at different 
times of growth. In Figure 25 the growth behavior of recombinant E. coli BL(21) cells 
containing the overproducing plasmid pET-28a is shown. A lag phase of one hour was 
observed in the growth of the cells. The exponential phase was completed within 10 
hours of inoculation, after which the cells entered their stationary phase. In the right side 
we have the SDS-PAGE image of human p22HBP purification by Ni-NTA column. The 
image shows a good expression of the protein in different conditions and the position of 
the bands suggests that the protein purified has more than 20 kDa which is similar to 
that predicted for human p22HBP. Only with the gel image we cannot say where the 
maximum expression was achieved. For that, we have concentrated and quantified the 
purest fractions (75, 175 and 500 mM imidazole) for each induction moment and the 
results are listed in Table 5. 
 
 
 
 
Figure 25: LEFT: Growth curve of human p22HBP. In the vertical axes we have the 
Logarithm of Absorbance (BLUE) and biomass concentration (RED) as a function of 
the number of hours. RIGHT:  SDS-PAGE image of human p22HBP testing of the 
induction moment. A-D: 0 to 4h supernatant; E-H: 0 to 4h 75 mM imidazole; M: 
molecular weight standard. 
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In the Table 5 human p22HBP concentrations resulted from time of induction testing 
were registered and the analysis of the values shows a direct relation between the time 
of induction and the amount of protein over-expressed and purified up to 2h. We can see 
that protein concentration increases with the time. However the data also shows that 
when we induce the cells after 4h of incubation in M9 medium the protein concentration 
decreases. Analyzing the growth curve (Figure 25), we can see that during the first two 
hours the cells are in the lag phase, where in theory most of the cellular machinery is 
directed to keep a regular number of cells during an adaptation period in a new medium 
(M9). After 2 hours in M9 medium, we can see that the cells are in an exponential 
growth phase. In this phase the cell machinery is directed to the synthesis of the target 
gene while growing. When inducing protein synthesis after 4 hours of adaptation in M9 
medium, the data shows that the amount of protein produced is lower than that verified 
after 2 hours, even though the cells are still in an exponential growth phase where the 
heterologous product production should increase as the cell concentration increases. The 
decreasing amount of protein produced was expected only when cells start reaching the 
stationary phase, but this situation was not the verified.  The results listed below (Table 
5) suggests that the best time to induce the production of human p22HBP by E. coli 
BL21(DE3) containing pET-28a plasmid, is after 2h of growing the cells in M9 
medium. 
 
 
Table 5: Relation between the time of induction and the human p22HBP purified from 
the purest fractions (75, 175 and 500 mM imidazole) 
Time of Induction (h) Concentration (µM)* ± 0.040 
0 14.2 
1 16.2 
2 19.2 
4 17.5 
*protein volume = 3.5 mL 
 
 
After determining the optimum starting time of induction, the effect of the inducer 
concentration on the efficiency of the induction was examined by using 0, 0.1, 0.5 and 1 
mM IPTG. The cells were all induced at the same time, after 2 hours of growth in M9 
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medium. The gel image of important fractions and the protein concentrations are shown 
below (Figure 26 and Table 6). 
 
 
Figure 26: SDS_PAGE image of IPTG concentration testing. M: molecular weight 
standard; A-C: 0.1, 0.5 and 1.0 mM IPTG from 75 mM imidazole; D-E: 0.5 and 1.0 mM 
IPTG from supernatant. 
 
 
Table 6: Relation between the concentration of IPTG used and the amount of protein 
produced and purified. 
IPTG concentration (mM) Concentration (µM)* ± 0.040 
0 0.0 
0.1 22.5 
0.5 20.8 
1 21.4 
 
 
 
The SDS-PAGE (Figure 26) shows protein bands at positions that were predicted for 
human p22HBP. The comparation of protein concentrations (Table 6) shows, as 
expected, that IPTG concentration is an important factor in T7 RNA polymerase 
production, which is fundamental for transcription of the target genes. This is 
concordant with the absence of protein produced when not inducing the cells with any 
IPTG. The analysis of all results suggests that 0.1 mM of IPTG is the best concentration 
to use, which gives good protein yields using a minimum amount of the inducer. 
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Cell lysis was performed by sonication and also optimized. The parameter tested was 
the sonication time. Here three different periods of Sonication were tested: 6, 12 and 20 
min. The results are listed below (Figure 27 and Table 7). 
 
 
Figure 27: Gel image of Sonication optimization. M: molecular weight standard; A, D, 
G: supernatants; B, E, H: 75mM imidazole; C, F, I: 175mM imidazole. 
 
 
Table 7: Relation between the sonication duration and the human p22HBP 
concentration after purification. 
Sonication  duration (min) Concentration (µM)* ± 0.040 
  
6 18.6 
12 26.3 
20 28.5 
*V=3.5 mL 
 
 
For the sonication testing, the SDS-PAGE image also shows protein bands at positions 
expected for human p22HBP. In the image we can see the increasing protein amount 
with the duration of the cell lysis. The gel results are confirmed with the protein 
concentration data after purification (Table 7). The protein concentration values suggest 
that there is a direct relation between the sonication duration and the amount of protein 
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extracted from the cells pellet, which is consistent with the fact that E. coli is not a good 
expression system in what concerns to its ability to release the heterologous proteins 
into the growth medium.  
 
 
4.2. Human p22HBP structural studies 
4.2.1. Overexpression and purification of Isotopic labeled 
human p22HBP 
 
The labeling of human p22HBP samples was accomplished by growing the E. coli 
(pET-28a) cells in M9 medium with 15NH4Cl, 
13C-glucose or both. Below (Figure 27) 
we can see the purification of a sample labeled with 15NH4Cl used for the studies of 
interaction with porphyrins. In the SDS-PAGE image we can see the protein expression 
profile after purification with an imidazole gradient in a NI-NTA column. In the gel we 
can see that the target protein band appears in a position expected for human p22HBP 
(more than 20 kDa). The gel also shows that the gradient of imidazole used (10-500 
mM) was good because the protein was purified in a few steps and purest fractions were 
collected in the fraction 75 (mainly), 175 and 500 mM (do not appear in the gel) mM 
imidazole.  These fractions were then gathered and concentrated. At right (Figure 28) 
the UV-Vis spectra of the protein is shown.  
 
Figure 28: LEFT: Gel image of 15N human p22HBP. M: molecular weight standard; A 
to I: protein extract, pellet, 10, 20, 50, 75, 175, 500 mM. RIGHT: Absorbance of human 
p22HBP as a function of wavelength. 
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The concentration of human p22HBP is calculated by measuring the absorbance at 280 
nm absorbance which is mainly a measurement of the number of Trp in the protein. The 
absorbance peak at 400 nm is caused by heme binded to the protein. 
 
 
 
 
Figure 29: Mass spectra of human p22HBP.  
 
 
The molecular mass of human p22HBP was accurately determined by mass spectra 
(Figure 29) which gave 22169.6 Da as expected for human p22HBP with a histidine 
tag. A theoretical molecular weight for human p22HBP was previously calculated using 
a biochemical protein parameter tool found in the Expasy (Bioinformatics Resource 
Portal) website based in the number and type of amino acids present in the sequence. 
The theoretical value was 22219 Da. The difference observed for the theoretical and 
experimental value is due to the fact that the protein was labeled. 
 
 
4.2.2. 1D 
1
H/2D 
1
H,
15
N NMR 
 
The first NMR spectra acquired for human p22HBP was a 1D spectra which is very 
simple and fast to acquire. A good 1D NMR spectra usually means that the sample is 
good and we can use it to perform other kind of experiments (2D and 3D) which are the 
only way to extract important information (resonances of 1H, 15N and 13C) for 
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biomolecular structure elucidation. A 1D spectrum of human p22HBP was acquired at 
293K (Figure 30) using a 1 mM protein sample. We can see how crowded this 
spectrum is due to overlap of resonances.  
 
 
 
 
Figure 30: 1D spectrum of 1 mM human p22HBP acquired at 293K. 
 
 
Being a relatively large protein in terms of NMR structure determination, using the 
conventional methods developed by Wuthrich we find two major problems: first, the 
large number of resonances causes signal overlap; second, the NMR signals relax faster, 
which leads to line broadening and poor sensitivity. To overcome this problem, the 
protein is labeled with 13C/15N and then pulse sequences based on the TROSY are used 
in the 2D/3D spectra to reduce transverse relaxation, thus obtaining sharper and more 
intense signals. 
 
In Figure 31, an overlay of TROSY spectra of 15N labeled human p22HBP acquired at 
500 and 600 MHz is shown. This spectrum shows a lot of 1H,15N  discrete cross-peaks 
detected, corresponding to the non-proline NH correlations from the amino acids in 
human p22HBP.  
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Figure 31: Superimposed 1H,15N TROSY spectrum of 1 mM human p22HBP recorded 
at 500 MHz (RED) and 1H,15N,13C recorded at 600 MHz (BLACK) is shown. Both 
spectrum were acquired at 293 K in 50 mM phosphate/ 300 mM NaCl buffer at pH 8.0. 
 
 
Both TROSY spectrum (Figure 31) of 15N p22 HBP and 15N/13C human p22HB sample 
showed a good chemical shift dispersion which was indicative of a folded protein. The 
number of signals expected was 185 NH correlations but the analysis showed less than 
that number mainly because of the overlay. Analysis of both spectra showed that they 
can be superimposed. It is known that the higher the strength of the magnetic field 
applied, more sensitive NMR is in detecting the signals when using the same sample 
concentration. In the boxes: down - region of the Trp side-chain residues; up – 
backbone Gly. Both group of spins appears in a characteristic frequency range which  
allowed their identification by comparation with data from BMRB (Table 2). As 
necessary premise to calculate a structure by NMR, we carried out 3D heteronuclear 
experiment to assign the 1H, 13C and 15N backbone chemical shifts of the protein. The 
assignment strategy will be described in the following section. 
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4.2.3. Sequence-specific resonance assignment 
 
The sequence assignments of human p22HBP were obtained by a combination of 
approaches: triple resonance experiments, human/murine p22HBP structure alignment 
and porphyrin titration experiments. For the first strategy a labeled 15N/13C human 
p22HBP samples were used with a combination of 2D 1H,15N TROSY and 3D trHNCO, 
trHN(CO)CA and trHNCA (Table 8) spectra, which correlates the backbone chemical 
shifts to establish the sequential connectivity between amino acids.  
 
 
Table 8: 3D experiments recorded and observed backbone chemical shift correlations. 
TROSY-type experiments Dimensionality Observed correlation 
HNCA 3D 
13Cα(i)-15N(i)-1HN(i) 
13Cα(i-1)-15N(i)-1HN(i) 
 
HN(CO)CA 3D 
13Cα(i-1)-15N(i)-1HN(i) 
 
HNCO 3D 13CO(i-1)-15N(i)-1HN(i) 
 
 
 
The sequential backbone assignment was carried out semi-automatically using the 
program CARA. All peaks were picked manually. Generic spin systems, that are 
generated automatically when a peak is peaked, have been matched mainly using the 
TROSY-HNCA spectrum. If the signals of interest were present in the TROSY-
HN(CO)CA, this spectrum was used for the distinction between Ci and Ci-1, otherwise 
this was determined from the relative signal intensities in the HNCA. Sequential peaks 
are normally less intense compared to intraresidue signals. Although the TROSY-
HNCO is highly sensitive, it provides only one C'i-1 peak per residue and therefore does 
not allow the establishment of connectivities between generic spin systems. Generic 
spin systems which could be matched were manually connected leading to chains of 
various lengths. The obtained peptide segments were mapped to the protein sequence 
using a probability tool matching, which is an automatic strip matcher that gives the 
user all the best candidate for successors and predecessors of a specific system. The 
bigger the fragment is, less ambiguity the tool retrieves, being very helpful for 
fragments matching. Only unambiguous assignments were taken into account and a 
short sequential section is presented below (Figure 32).  
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In figure 29 we have slices from trHN(CO)CA and trHNCA spectra where we could 
assign the Cα resonances of human p22HBP (as shown in the following figure from Thr 
43 to Val 46). The assignment using the triple resonance experiments is complemented 
with the comparation of the experimental chemical shift values with the average values 
from the BMRB database (Table 2). 
 
 
 
Figure 32: Sequential backbone assignments of the Thr 43 to Val 46 resonances for 
human p22HBP. A) trHN(CO)CA and B) trHNCA spectra acquired in the 15N/13C 
labeled human p22HBP. 
 
 
 
The sequential walk was of great importance up to a certain point where 42 % of the 
residues in the human p22HBP sequence could be assigned. From that point on the task 
became difficult due to the increasing number of overlay peaks. To overcome this 
problem, we started using a second strategy based on the alignment of the two versions 
of p22HBP sequences: the human and the murine. If we perform a blast search in 
human and murine p22HBP using the blast tool from NCBI, we find that the first is a 
polypeptide with 189 amino acids and accession number NP_057071, and the second is 
a polypeptide with 190 amino acids and accession number NP_038574 (Figure 33).  
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Figure 33: Protein sequence alignment between murine and human p22HBP using 
CLUSTALW 40. 
 
 
 
Looking at the alignment we can extract information such as the presence of 1 gap and 
the presence of 164/189 (87%) identical amino acids, which is a proof of the great level 
of homology between both polypeptides. Sharing this degree of homology, the 
resonance signals of conserved residues in both human and murine p22HBP should 
appear in the same region of a HSQC/TROSY spectrum.  
The Figure 34 shows the superposition of 1H,15N TROSY NMR spectrum of both 
proteins, acquired at 20ºC. In this spectrum we confirm the great level of homology in 
the two sequences as can be seen by the proximity of many murine resonances to human 
resonances, which was already expected. This strategy allows the identification of 
residues present in conserved sequences, without the need for triple resonance 
experiments (Figure 35). It can also be complementary to triple resonance experiments 
because it can be confirmed if a conserved residue was correctly assigned or not.  
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Figure 34: Superimposed TROSY spectra of murine p22HBP (BLUE) and human 
p22HBP (RED) at 20ºC. 
 
 
 
The two strategies used until now, triple resonance experiments and murine/human 
p22HBP alignment, followed by overlay of the spectra, allowed the correct assignment 
of many signals but we still had many resonances that could not be assigned possibly 
due to proximity to non conserved residues or because of little or no conservation. 
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Figure 35: TROSY spectrum of human p22HBP (RED)   and murine p22HBP (BLUE) 
showing the assignment of Ala 114 using the second strategy and Ala 148 using the 
third strategy.  
 
 
 
 
Figure 36: A region of the spectrum where the assignment using the second strategy 
was more difficult due to the overlap of the signals. RED: human p22HBP; BLUE: 
murine p22HBP. 
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Figure 35 shows how the overlay of murine with human p22HBP was helpful in 
assigning Ala 114. Looking at the alignment (Figure 33) Ala 114 is between prolines 
which has no signal in HSQC/TROSY spectrum so then the assignment of this residue 
could not be carried out with triple resonance experiments since we cannot link it to any 
other residue. However this residue is in a conserved sequence so then, superimposing 
the spectra of both proteins, we could see that the signals from Ala 114 for both proteins 
appear close to each other. In Figure 36 we can see a region of the spectrum where the 
overlap of resonances made difficult to assign the spectrum. The assignment of the five 
residues was performed using triple resonance experiments (Asp 48 and Ser 93) and 
human/murine spectrum overlay (Met 59, Phe 108 and Thr 149). To assign further the 
backbone chemical shifts we used data from porphyrins titration studies that we will 
analyze in the following section. 
 
 
4.3. Interaction studies 
4.3.1. Chemical shift perturbation mapping 
 
To better understand the binding mechanism to heme, NMR-monitored titrations were 
carried out to observe interactions between human p22HBP and hemin or PPIX. We 
acquired three spectra, human p22HBP:Tween,  human p22HBP:Hemin and human 
p22HBP:PPIX. The sample with Tween was used as blank and the assignment was 
performed in order to eliminate the effect of chemical shift differences due to the 
presence of Tween. The binding kinetics that results in a slow exchange of protein 
conformational state, from free to bound, induces perturbation in sign and magnitude of 
the protein chemical shifts. This data is of great importance because the perturbations 
are higher in the nucleus near the binding pocket, so then finding these residues allows 
finding the place in the molecule where the interaction takes place. The analysis of the 
perturbation pattern presented by the residues, from free to bound state, allowed us also 
to make more assignments.  As shown below for a region of spectra, the peaks from free 
to bound state presents a linear distribution (Figure 37).  
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Figure 37: 
1H,15N TROSY of human p22HBP titrated with porphyrins at 20ºC. RED-
human p22HBP free, GREEN-human p22HBP titrated with PPIX, BLUE-human 
p22HBP titrated with hemin. 
 
 
Figure 35 shows the overlay of the 15N-labeled human p22HBP 1H,15N TROSY spectra 
recorded without (red) or with hemin (blue) and PPIX (green) (1:1.1 ratio). The first 
thing to notice is the dependency of protein chemical shifts on the nature of the ligand 
binding, which was expected because while the hemin is an iron containing porphyrins, 
PPIX is not. It has long been known that the effect of unpaired electrons on NMR 
spectral parameters such as chemical shifts and relaxation times is a valuable source of 
information on molecular structure. Electron-nuclear interactions involving a 
paramagnetic center with rapidly relaxing electron spins in an anisotropic ligand field 
give rise to large shifts in NMR frequencies 41. The arrows (Figure 37) show the linear 
relation in chemical shift dispersion between the two porphyrins during binding with 
human p22HBP. The signal of NH group in HBP bound to PPIX appears closer to the 
signal of the NH group of the protein free and then the corresponding NH in hemin 
bound HBP.  
The magnitude of the differences in chemical shift of the protein upon binding to the 
porphyrins was also studied. Significant chemical-shift changes were observed in 
several areas of the spectra.  Figure 38 shows the magnitude of the chemical-shift 
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change, for each assigned residue of the polypeptide. The biggest changes were seen for 
residues 42 to 56 and 139 to 179 which suggest that these residues participate in binding 
to porphyrins. In previous studies in murine p22HBP the residues found to have larger 
chemical shifts were 63, 139 and those in the region from 171-179 as can be seen in 
Figure 38 
9.  
 
 
 
 
Figure 38: Experimental 1H chemical shift differences observed for human p22 HBP 
upon binding of PPIX or Hemin plotted as a function of the human p22HBP amino acid 
sequence. 
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Figure 39: Comparation of the experimental 1H chemical shift differences observed for 
human p22 HBP upon binding of PPIX or Hemin with the reported 1H chemical shift 
differences observed for murine p22 HBP upon binding the same porphyrins. 
 
 
Analyzing the overlay of both data (Figure 39) we can see that some of the residues 
with larger chemical shift change are the same (42 to 56 and 139 to 179), however, for 
murine p22HBP, 63 is one of the residues with larger chemical shift change, which is 
not concordant with the data obtained here, where the 63 almost does not shift at all. 
The plot shows that 63 appears in a region where few assignments were performed due 
to the overlap. In any case, the superposition of the murine/human titration data shows 
the same pattern in chemical shift differences which can mean that human and murine 
p22HBP interacts in the same way with these ligand and the same residues participate in 
this process. In the plot there are some regions far from the binding site that still do not 
present a chemical shift difference and these regions are the ones that we could not 
assign.  
As referred previously, the analysis of the chemical shift differences data was of great 
utility mainly to confirm assignments but it also helped to assign Ala 148 (Figure 35) 
which could be assigned only using the data from the titration. The combination of all 
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the strategies mentioned back resulted in the assignment of 68% of the resonances 
(Figure 40, 41 and Table A2 (Appendix)).  
 
 
 
Figure 40: Human p22HBP residues assigned using the combination of: RED-triple 
resonance experiments (42%)); Green-sequence alignment (25%) corresponding to 68% 
and BLUE- titration data (0.5%). 
 
 
 
 
 
Figure 41: TROSY spectrum showing the assignment of 68 % of the human p22HBP 
residues. 
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4.3.2. Human p22HBP tetrapyrrole dissociation constants 
 
In this section intrinsic fluorescence quenching was used to quantify binding constants 
for human p22HBP with hemin and PPIX. Recent studies performed in murine p22HBP 
reported values for the dissociation constants obtained for the PPIX and hemin 
complexes were 0.5 and 3.0 nM, respectively 9. By using the same methodology we 
expect to get similar values for human p22HBP. The graph below (Figure 42) shows 
the intrinsic fluorescence quenching at maximum emission (340 nm) for human 
p22HBP as a function of increasing concentration of hemin and PPIX. Different 
concentrations (5 and 10 uM) of hemin and PPIX were tested and the dissociation 
constants were determined by non-linear fitting which gave the binding values that are 
represented in the following graph. 
 
 
 
 
Figure 42: Intrinsic human p22HBP tryptophan fluorescence at maximum emission 
(340 nm) as a function of increasing PPIX or hemin concentrations.  
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In Figure 42 it can be observed that each ligand caused efficient quenching of the p22 
HBP tryptophan emission.  
 
 
 
 
Figure 43: Dissociation constant values obtained for hemin and PPIX complexes. 
 
 
Analyzing the data (Figure 43) we find that the values of dissociation constant obtained 
for the hemin and PPIX complexes were in the nanomolar range as reported previously 
for murine p22HBP. For the literature we know that even though the dissociation 
constant is higher for the hemin complex, the difference is not as pronounced as that 
obtained for human p22HBP here. Comparing with the literature, the PPIX presents a 
very similar dissociation constant, even though the concentration of the porphyrins is 
different (1.75 μM for hemin and 2.0 μM for PPIX) and it seems that the concentration 
of the porphyrins used is not so relevant for determining binding strength.  
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4.3.3. Separating human p22HBP from tetrapyrrole 
 
In this section the separation of the human p22HBP from PPIX was tried with urea, 
which is  widely used to assess protein unfolding 42. After using a human:PPIX sample 
(1:1.1 mol ratio) for interaction studies, we wanted to separate the protein from the 
tetrapyrrole. First PPIX was added to the sample (~200 µL of human p22HBP:PPIX) to 
achieve 2.50 mL. Dialysis was carried out at 4ºC in this sample for 24 hours. After then 
the sample was diluted to 22.5 mL and loaded into a Ni-NTA column and the flow 
through was collected. Then, the column was washed first with 50 mM phosphate/300 
mM imidazole buffer and then with the same buffer containing 175 mM imidazole. The 
eluates were recovered, concentrated and the protein and the PPIX concentration were 
quantified by UV-Vis and the results are listed below (Table 9). Figure 44 shows the 
absorbance profile for the samples as a function of the wavelength. The protein 
absorbance peak appears at 280 nm while the PPIX appears at 400nm.  
 
 
 
 
 
Figure 44: Absorbance profile of human p22HBP:PPIX complex after dyalisis and 
purification. Purple – initial sample, Red – 50 mM phosphate/300 mM NaCl buffer, 
Green – 50 mM phosphate/300 mM NaCl /175 mM imidazole, Blue – Flow through. 
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Table 9: Protein and PPIX concentrations for the different samples. 
Samples 
Concentration (µM) 
Human 
p22HBP 
PPIX 
Initial 8.63 5.87 
Flow through 2.46 2.43 
Phosphate buffer 0.90 0.74 
Phosphate buffer 
+175 mM imidazole 
4.90 1.89 
 
 
 
Analysis of the data (Figure 44 and Table 9) shows that the purification column was 
not functioning correctly because the flow through and the phosphate buffer presented 
protein. When using this Ni-NTA column, for the protein concentration loaded, all the 
protein should complex with Ni2+ in the resin. Only the addition of a gradient of 
imidazole should break this interaction, which was not the case because when we 
washed the column with phosphate buffer the column also lost some protein. For PPIX, 
the data shows that the separation of the complex was not successful. The tetrapyrrole 
was washed always at same time with the protein.  Although more experiments are 
needed and detailed experimental setups has to be carried out in order to determine if 
urea can separate the complex and if it is true, this may allow the reutilization of the 
protein samples. 
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Chapter 5 – General Discussion and Conclusions 
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In this work, in order to perform the proposed studies, the gene encoding the human 
p22HBP was cloned in the pET-28a plasmid, which was used to transform E. coli 
BL21(DE3) strains. To carry out structural studies by NMR, a good amount of quality 
sample is necessary, so then studies to optimize the parameters with influence in the 
protein yield are very important. In this work, the optimization of parameters (the time 
of induction, IPTG concentration and sonication duration) with influence in protein 
production were studied  and the best results were obtained when inducing the target 
gene expression after 2 hours of growing the cells in M9 medium, using 0.1 mM of 
IPTG and 20 min of sonication to break the cells. For the first time, the sequence-
specific resonance assignment of the human version of p22HBP was carried out using a 
combination of methods: triple resonance experiments (makes use of 15N/13C isotopic 
labeling), human/murine sequence and spectrum at 293K overlay and finally the data 
from interaction studies with tetarpyrroles. This resulted in assignment of 68% of the 
NH cross peaks present in the 1H,15N TROSY spectrum. All these methods were 
important because in certain regions of the spectrum, the resonances overlap made 
difficult the assignment and we could choose the best one to use in that moment. In 
future the assignment can be totally concluded labeling the protein with 15N/13C/2H 
which combed to HNCACB will decrease the resonances overlap allowing the spins to 
be easily assigned. During preparation and storage of the proteins, we notice that the 
buffer can cause a fast protein precipitation when a protein sample containing 50 mM 
phosphate/ 300 mM NaCl is stored at -20ºC. To store this sample, a desalting in PD-10 
column is required, in order to eliminate the NaCl.   
 
Analysis of the chemical shift changes of human and murine p22 HBP in upon 
tetrapyrrole binding indicates that the same residues are present in the binding pocket, 
so then they are important in the way the protein interacts with the tetrapyrroles. In 
addition, the human p22HBP binding affinities were determined and they suggests that 
they are in the nanomolar range as reported for murine p22HBP, which suggest that  the 
porphyrins binds with high affinity even though the difference in the values obtained for 
PPIX and hemin. This difference may be related to errors during the experimental 
procedure, so then more fluorescence quenching studies can be performed in order to 
assess better conclusions. Finally, an attempt was carried out to separate the protein 
from the PPIX. For that a dialysis was performed and after then a purification in Ni-
NTA column was carried out and the results showed that this temptative failed. 
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However the  results suggests that the column used was not working well, which means 
that more studies have to be performed in order to assess this conclusion. The advantage 
of the complex separation is the reutilization of the protein sample avoiding the 
continuously over-expressions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                    
                                                                            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6 – References 
70 
 
1 Wijayanti, N., Katz, N. & Immenschuh, S. Biology of heme in health and 
disease. Curr. Med. Chem. 11, 981-986 (2004). 
2 Cunha, L. F. L. Genetic, biochemical and biophysical studies of the heme 
biosynthetic pathway phD thesis, Universidade do Porto (2008). 
3 Ajioka, R. S., Phillips, J. D. & Kushner, J. P. Biosynthesis of heme in mammals. 
Biochim. Biophys. Acta-Mol. Cell Res. 1763, 723-736 (2006). 
4 Taketani, S. et al. Molecular characterization of a newly identified heme-binding 
protein induced during differentiation of urine erythroleukemia cells. Journal of 
Biological Chemistry 273, 31388-31394 (1998). 
5 Zylka, M. J. & Reppert, S. M. Discovery of a putative heme-binding protein 
family (SOUL/HBP) by two-tissue suppression subtractive hybridization and 
database searches. Molecular Brain Research 74, 175-181 (1999). 
6 Sato, E. et al. SOUL in mouse eyes is a new hexameric heme-binding protein 
with characteristic optical absorption, resonance Raman spectral, and heme-
binding properties. Biochemistry 43, 14189-14198 (2004). 
7 Blackmon, B. J., Dailey, T. A., Xiao, L. C. & Dailey, H. A. Characterization of a 
human and mouse tetrapyrrole-binding protein. Archives of Biochemistry and 
Biophysics 407, 196-201 (2002). 
8 Babusiak, M., Man, P., Sutak, R., Petrak, J. & Vyoral, D. Identification of heme 
binding protein complexes in murine erythroleukemic cells: Study by a novel 
two-dimensional native separation - liquid chromatography and electrophoresis. 
Proteomics 5, 340-350 (2005). 
9 Dias, J. S. et al. The first structure from the SOUL/HBP family of heme-binding 
proteins, murine P22HBP. Journal of Biological Chemistry 281, 38966-38966 
(2006). 
10 Micaelo, N. M., Macedo, A. L., Goodfellow, B. J. & Félix, V. Tetrapyrrole 
binding affinity of the murine and human p22HBP heme-binding proteins. 
Journal of Molecular Graphics and Modelling 29, 396-405 (2010). 
11 Qoronfleh, M. W., Hesterberg, L. K. & Seefeldt, M. B. Confronting high-
throughput protein refolding using high pressure and solution screens. Protein 
Expression and Purification 55, 209-224, (2007). 
12 Caruso, C. S. Clonagem, Expressão e Caracterização de Proteínas 
Recombinantes de Xylella Fastidiosa PhD thesis, Universidade de São Paulo 
(2007). 
13 Itakura, K., T. Hirose, R. & Riggs, A. D. Expression in Escherichia coli of a 
chemically synthesized gene for the hormone somatostatin. Science 198, 1056-
1063 (1977). 
14 Schmidt, F. R. Recombinant expression systems in the pharmaceutical industry. 
Applied Microbiology and Biotechnology 65, 363-372, (2004). 
15 Rai, M. & Padh, H. Expression systems for production of heterologous proteins. 
Current Science 80, 1121-1128 (2001). 
16 Schumann, W. & Ferreira, L. C. S. Production of recombinant proteins in 
Escherichia coli. Genetics and Molecular Biology 27, 442-453 (2004). 
17 Kraljevic, J. B. & Mrzljak, G. P. Supramolecular Structure and Function 10.     
Springer (2011). 
18 Makrides, S. C. Strategies for achieving high-level expression of genes in 
Escherichia coli. Microbiological Reviews 60, 512-& (1996). 
19 Novagen. pET System Manual (2011). 
20 Dingermann, T., Steinhilber, D., folkers, G. Methods and Principles in 
Medicinal Chemistry Vol. 21. Wiley (2004). 
71 
 
21 Arnau, J., Lauritzen, C., Petersen, G. E. & Pedersen, J. Current strategies for the 
use of affinity tags and tag removal for the purification of recombinant proteins. 
Protein Expression and Purification 48, 1-13 (2006). 
22 QIAGEN. A handbook for high-level expression and purification of 6xHis-
tagged proteins (2003). 
23 http://www.enciclopedia.com.pt/print.php?type=A&item_id=1038 (2011). 
24 Wuthrich, K. NMR of Proteins and Nucleic Acids. Wiley (1986). 
25 Kendrew, J. C. et al. Structure of Myoglobin: A Three-Dimensional Fourier 
Synthesis at 2 Å. Resolution. Nature 185 (1960). 
26 Koskela, O. NMR Spectroscopy of multi-domain proteins:immunoglobulin-like 
domains of human filamin A phD thesis, University of Helsinki (2009). 
27 Kai, L. Development of computational methods for the rapid determination of 
NMR resonance assignment of large proteins phD thesis, National University of 
Singapore (2003). 
28 Teng, Q. Structural Biology: Practical NMR Applications. Springer (2005). 
29 Evans, J. N. S. Biomolecular NMR Spectroscopy. Vol. 70. Oxford university 
press (1996). 
30 Pervushin, K. Impact of Transverse Relaxation Optimized Spectroscopy 
(TROSY) on NMR as a technique in structural biology. Quarterly Reviews of 
Biophysics 33, 161-197 (2000). 
31 Schubert, M. Development and application of novel triple-resonance 
experiments for the assignment of protein NMR spectra (1998). 
32 Sattler, M., Schleucher, J. & Griesinger, C. Heteronuclear multidimensional 
NMR experiments for the structure determination of proteins in solution 
employing pulsed field gradients. Progress in Nuclear Magnetic Resonance 
Spectroscopy 34, 93-158 (1999). 
33 Goto, N. K. & Kay, L. E. New developments in isotope labeling strategies for 
protein solution NMR spectroscopy. Current Opinion in Structural Biology 10, 
585-592 (2000). 
34 Salzmann, M., Wider, G., Pervushin, K., Senn, H. & Wuthrich, K. TROSY-type 
triple-resonance experiments for sequential NMR assignments of large proteins. 
J. Am. Chem. Soc. 121, 844-848 (1999). 
35 Fernandez, C. & Wider, G. TROSY in NMR studies of the structure and 
function of large biological macromolecules. Current Opinion in Structural 
Biology 13, 570-580 (2003). 
36 Meyer, B. & Peters, T. NMR Spectroscopy techniques for screening and 
identifying ligand binding to protein receptors. Angewandte Chemie-
International Edition 42, 864-890 (2003). 
37 Clarkson, J. & Campbell, I. D. Studies of protein-ligand interactions by NMR. 
Biochemical Society Transactions 31, 1006-1009 (2003). 
38 Nienhaus, G. U. Methods in Molecular Biology. Humana Press (2005). 
39 Lakowicz, J. R. Principles of Fluorescence Spectroscopy. Plenum (1999). 
40 Thompson, J. D., Higgins, D. G. & Gibson, T. J. Clustal-w - Improving the 
sensitivity of progressive multiple sequence alignmnent through sequence 
weighting, position-specific gap penalties and weight matrix choice Nucleic 
Acids Res. 22, 4673-4680 (1994). 
41 Gochin, M. & Roder, H. Protein-structure refinement based on paramagnetic 
NMR shifts - Applications to wild- type and mutant forms of cytochrome-C. 
Protein Science 4, 296-305 (1995). 
72 
 
42 Bennion, B. J. & Daggett, V. The molecular basis for the chemical denaturation 
of proteins by urea. Proceedings of the National Academy of Sciences of the 
United States of America 100, 5142-5147 (2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
73 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                    
                                                                            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7 – Appendix 
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 Table A 1: Fluorescence quenching measurements for Kd determination of the human 
p22HBP(100 nm) – PPIX (10 µM) complex. 
 
 
 
 
Table A 2: Values of chemical shits for the nucleus assigned in the human p22HBP. 
Residue 
δ 
1
H
N
 
[ppm] 
δ 
15
N 
[ppm] 
δ 
13
CO 
[ppm] 
δ 
13
Cα 
[ppm] 
1     
2     
3     
4     
5     
6     
7     
8     
9 8.79 116.4 173.9 55 
10 8.92 134.02 171.364 56.28 
13 8.48 123.48  54.81 
14 7.23 119.44 170.419 56.93 
15     
16     
17     
18     
19 8.22 117.48 173.907 50.89 
20 9.33 127.12 172.766 60.7 
21 9.28 130.6 173.386 53 
22 7.81 111.2 174.820 55.71 
23     
24 7.63 108.66 172.147 41.91 
25 7.32 118.34  63.27 
26    59.18 
27 7.83 121.37 172.701 55.04 
28     
29 7.95 121.97 173.027 59.66 
30     
31 8.56 120.13 175.570 52.43 
32 8.85 118.89 170.745 51.67 
33 8.98 127.51 171.346 51.41 
Intensity 
(340nm) 
VHEMIN 
ad. (L) 
VHEMIN 
ad. 
total(L) 
Dil. factor 
Int.(340n
m) (corr) 
nadic. /mol 
[PPIX]cel
l /M 
[soul]cell 
/M 
Normaliz
ation 
3.87E+06 0.00E+0 0.00E+0 1.00E+0 3.87E+06 0.00E+0 0.00E+0 1.00E-07 1.00E+0 
3.38E+06 3.00E-06 3.00E-06 1.00E+00 3.39E+06 3.00E-11 1.50E-08 9.99E-08 8.20E-01 
2.69E+06 5.00E-06 8.00E-06 1.00E+00 2.70E+06 7.99E-11 3.98E-08 9.96E-08 5.58E-01 
2.04E+06 5.00E-06 1.30E-05 1.01E+00 2.05E+06 1.30E-10 6.45E-08 9.94E-08 3.14E-01 
1.66E+06 5.00E-06 1.80E-05 1.01E+00 1.67E+06 1.80E-10 8.91E-08 9.91E-08 1.73E-01 
1.46E+06 5.00E-06 2.30E-05 1.01E+00 1.48E+06 2.30E-10 1.14E-07 9.89E-08 9.86E-02 
1.27E+06 1.00E-05 3.30E-05 1.02E+00 1.29E+06 3.30E-10 1.62E-07 9.84E-08 2.91E-02 
1.22E+06 1.00E-05 4.30E-05 1.02E+00 1.25E+06 4.30E-10 2.10E-07 9.79E-08 1.27E-02 
1.19E+06 1.00E-05 5.30E-05 1.03E+00 1.22E+06 5.29E-10 2.58E-07 9.74E-08 0.00E+00 
1.18E+06 1.00E-05 6.30E-05 1.03E+00 1.22E+06 6.29E-10 3.05E-07 9.69E-08 3.40E-04 
75 
 
34 9.18 125.48 172.897 50.86 
35 8.91 125.66 171.038 47.95 
36 9.21 125.41 174.625 54.76 
37 8.88 124.68 172.831 50.86 
38 8.91 111.83  41.48 
39 9.03 112.08 169.375 41.15 
40 9.87 122.14 169.310 53.04 
41 9.09 120.33 172.962 53.76 
42 9.64 123.16 171.918 47.48 
43 9.59 114.23  54.52 
44 6.99 116.25 170.940 58.52 
45 9.17 130.08 171.332 52.24 
46 8.86 126.61 172.342 58.71 
47 8.85 120.08 178.668 58.23 
48 8.25 115.23 170.549 53.85 
49 7.85 118.56 178.276 50.71 
50     
51 8.59 122.2  65.13 
52 9.3 117.21 173.777 56.27 
53 7.22 119.05 170.940 55.65 
54 8.95 124.29 176.255 52.38 
55 8.61 119.45 175.896 55.38 
56 7.08 117.2 176.124 55.85 
57 7.27 116.58 116.576 54.85 
58 8.34 121.66 170.386 47.57 
59 8.2 115.58 173.092 54.85 
60     
61 6.9 113.61 175.961 57.14 
62     
63     
64 8.02 119.49 174.396 54.04 
65 7.35 122.11 174.331 55.66 
66     
67 7.7 107.35 173.190 41.63 
68 6.89 105.59  41.77 
69 8.72 122.83 171.788 58.28 
70 8.4 121.61 170.810 49.24 
71 9.43 120.47 175.916 54.28 
72 7.58 117.21 176.222 52.09 
73 7.94 112.53 173.744 43.62 
74     
75 8.64 114.93 174.233 52.33 
76 8.84 122.75 172.473 53.28 
77 7.81 107.46 175.798 45.1 
78 7.91 111.68 168.527 50.95 
79 8.69 117.87 175.048 54 
80     
81     
82 8.47 118.75  51.76 
83 7.53 120.67 174.527 51.33 
84 9.23 116.06 170.419 53 
85 10.08 126.32 169.832 48.24 
86 7.98 112 172.831 56.28 
87 9.1 116.78 170.940 52.56 
88     
89 9.45 119.87 173.744 49.61 
90     
91 7.87 114.94 176.450 50.51 
92 8.04 109.85 174.331 42.37 
93 8.16 115.42 171.038 55.84 
76 
 
94 8.72 119.61 173.069 58.88 
95 8.49 120.22 175.407 53.28 
96 8.42 118.73 176.222 54.74 
97 7.91 122.02 175.505 53.71 
98 8.71 123.89 170.549 52.6 
99 8.39 124.55 172.864 53.32 
100 9.43 130.8 172.473 60.74 
101 9.28 125.33 172.833 53.22 
102 8.75 127.64 171.918 51.94 
103 8.38 130.65 170.614 47.75 
104 7.29 130.16 171.788 55.65 
105     
106 10.15 123.72 173.875 54.32 
107 9.7 119.41 175.570 55.31 
108 8.28 114.46 171.560 57.72 
109 7.32 118.71 171.560 56.55 
110     
111     
112     
113     
114 8.97 129.13 173.125 47.46 
115     
116 7.52 119.79 176.907 56.84 
117 8.11 123.78 176.190 52.7 
118     
119 8.96 115.85 174.429 57.55 
120 8 124.74 170.093 58.22 
121 8.77 125.07 171.429 50.94 
122 8.38 120.81 170.777 58.26 
123 9.39 127.24 174.233 52.32 
124 8.87 121.98 171.429 52.13 
125 9.27 124.13 173.157 53.32 
126 8.91 124.69 171.592 53.22 
127 8.62 107.19 173.712 43.66 
128 7.7 114.43 170.516 56.69 
129 8.65 121.11  61.21 
130 8.49 117.23 170.712 58.03 
131 8.97 119 171.718 54.13 
132 9.42 116.51 171.788 53.08 
133     
134 8.17 127.91 172.440 55.31 
135     
136     
137 7.64 104.76 171.984 41.39 
138     
139 8.41 130.73 172.701 49.46 
140 9.52 123.89 173.288 51.27 
141 10.78 125.88 174.559 59.22 
142 8.68 115.9 174.266 52.32 
143 7.87 117.01 178.309 54.36 
144 8.09 119.22 185.417 59.09 
145 8.24 118.42 178.021 63.65 
146 8.12 123.19 176.255 52.75 
147     
148 9.05 127.62 171.103 51.65 
149 8.34 115.25 172.440 41.61 
150     
151 8.42 123.68 170.810 50.08 
152 8.33 118.22 172.407 56.61 
153     
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154     
155 7.63 119.29 181.048 52.27 
156 7.81 124.02 170.419 59.93 
157     
158 7.64 113.56 177.298 62.83 
159     
160 7.59 122.43 176.222 58.07 
161     
162     
163     
164     
165 9.11 118.04 170.745 51.51 
166     
167 7.97 121.08 172.994 51.03 
168     
169 8.67 119.46 171.429 52.6 
170     
171 8.48 107.92 172.994 43.09 
172     
173 7.77 117.41 172.440 56.69 
174     
175     
176     
177     
178     
179 7.21 115.94 173.679 52.84 
180     
181     
182 9.26 121.51 172.310 53.89 
183     
184 8.85 117.86 178.635 55.03 
185     
186 9.58 125.51 171.690 50.27 
187 8.99 122.44 173.255 50.41 
188     
189 8.38 131.05 170.647 49.46 
 
 
 
 
 
